Maureen Ross

MD, PhD
Medical Oncology

Cancers Treated:

Chronic Lymphocytic Leukemia Lymphoma Multiple Myeloma

Research Interests:

Bone marrow transplantation Hematological malignancies Clinical Trials in Stem Cell Transplantation and/or Hematologic Malignancies

About Maureen Ross

Positions

Roswell Park Comprehensive Cancer Center
  • Professor of Oncology
  • Department of Medicine - Transplant & Cellular Therapy

Background

Education and Training:

  • University of Miami, Miller School of Medicine, Miami, FL
  • PhD - Stanford University, Palo Alto, CA

Residency:

  • Duke University Medical Center, Durham, NC

Fellowship:

  • Duke University Medical Center, Durham, NC

Board Certification:

  • American Board of Internal Medicine
  • American Board of Medical Oncology

Professional Memberships:

  • American Society of Hematology
  • American Society for Blood and Marrow Transplantation
  • American Society of Clinical Oncology
  • 1990-1995 - Cancer and Leukemia Group B
  • 2010-Present - Cancer and Leukemia Group B

Clinical Trials

Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma
Learn More
Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol
Learn More
CTL019 Out of Specification MAP for ALL or DLBCL Patients
Learn More

Featured on Cancer Talk

Acute myeloid leukemia: Kathleen's story
Follicular lymphoma: Prudie's story

Publications

Full Publications list on PubMed

Chen GL, Wallace PK, Zhang Y, Tario JD Jr, Przespolewski AC, Becker J, Almyroudis NG, Ross M, Riches M, Segal BH, Brix L, McCarthy PL, Hahn T. Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen- Specific T Cells after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Nov;26(11):2147-2154. doi: 10.1016/j.bbmt.2020.07.024. Epub 2020 Jul 25. PMID: 32721522 Free PMC article.
 

Chen GL, Jeon M, Ross M, Liu H, Lee C, Hahn T, McCarthy PL, Kim C. Optical Coherence Tomography for Quantifying Human Cutaneous Chronic Graft-versus- Host Disease. Transplant Cell Ther. 2021 Mar;27(3):271.e1-271.e8. doi: 10.1016/j.jtct.2020.11.023. Epub 2020 Dec 16. PMID: 33781538 Free PMC article.
 

Herr MM, Rehman S, Zhang Y, Ho CM, Chen GL, Ross M, Hillengass J, Jacobson H, McKenzie R, Farrell K, Maqsood A, McCarthy PL, Hahn T. Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplantation Predicts Healthcare Utilization and Survival. Transplant Cell Ther. 2021 Oct;27(10): 875.e1-875.e9. doi: 10.1016/j.jtct.2021.06.021. Epub 2021 Jun 30. PMID: 34216792
 

Herr MM, Balderman SR, Wallace PK, Zhang Y, Tario JD Jr, Buxbaum NP, Holtan S, Ross M, McCarthy PL, Betts B, Maslak P, Hahn TE. Outcomes of human leukocyte antigen-matched related donor and haploidentical allogeneic hematopoietic cell transplantation recipients by immune profiles of recipients and donors. Transplant Cell Ther. 2024 May 25: S2666-6367(24)00428-7. doi: 10.1016/j.jtct.2024.05.018. Online ahead of print. PMID: 38801976